560 related articles for article (PubMed ID: 24838471)
1. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
2. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
4. Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.
Firl DJ; Kimura S; McVey J; Hashimoto K; Yeh H; Miller CM; Markmann JF; Sasaki K; Aucejo FN
Hepatology; 2018 Oct; 68(4):1448-1458. PubMed ID: 29604231
[TBL] [Abstract][Full Text] [Related]
5. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
6. Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator.
Díaz LA; Norero B; Lara B; Robles C; Elgueta S; Humeres R; Poniachik J; Silva G; Wolff R; Innocenti F; Rojas JL; Zapata R; Hunter B; Álvarez S; Cancino A; Ibarra J; Rius M; González S; Calabrán L; Pérez RM
Ann Hepatol; 2019; 18(2):325-330. PubMed ID: 31010794
[TBL] [Abstract][Full Text] [Related]
7. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
Mehta N; Dodge JL; Roberts JP; Yao FY
J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
[TBL] [Abstract][Full Text] [Related]
8. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
11. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
[TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.
Palmer WC; Lee D; Burns J; Croome K; Rosser B; Patel T; Keaveny AP; Pungpapong S; Satyanarayana R; Yataco M; Nakhleh R; Musto KR; Canabal AM; Turnage AK; Hodge DO; Nguyen JH; Harnois DM
Ann Hepatol; 2017; 16(3):402-411. PubMed ID: 28425410
[TBL] [Abstract][Full Text] [Related]
14. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
15. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
Mehta N; Heimbach J; Lee D; Dodge JL; Harnois D; Burns J; Sanchez W; Roberts JP; Yao FY
Transplantation; 2017 Sep; 101(9):2071-2078. PubMed ID: 28353492
[TBL] [Abstract][Full Text] [Related]
16. HCC patients suffer less from geographic differences in organ availability.
Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H
Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291
[TBL] [Abstract][Full Text] [Related]
17. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
Samoylova ML; Dodge JL; Yao FY; Roberts JP
Liver Transpl; 2014 Aug; 20(8):937-44. PubMed ID: 24797145
[TBL] [Abstract][Full Text] [Related]
18. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
